PMID: 696341Aug 1, 1978Paper

Interaction of vitamin E and selenium with the hepatotoxic agent dimethylnitrosamine

Acta Pharmacologica Et Toxicologica
J U Skaare, I Nafstad

Abstract

Pretreatment of rats with vitamin E, 0.02% w/w of the diet and a sc dose, 200 mg/kg, given 48 hrs. before dimethylnitrosamine, DMNA, was found to ameliorate the acute hepatotoxicity of DMNA (30 mg/kg) as reflected in reduced plasma asparagine-amino-transferase (AspAT) activity. This effect was confirmed by histological evaluation. No significant effect of DMNA on plasma levels of vitamin E was observed, however, DMNA significantly increased the hepatic level of vitamin E supplemented rats. Pretreatment with selenium, 0.5 mg/kg given intraperitoneally 48 hrs. before DMNA, was found to enhance the acute hepatotoxicity of DMNA as reflected in increased elevation of plasma AspAT activity. This effect was not confirmed morphologically. DMNA did not have any effect on the hepatic selenium state in selenium pretreated rats; however, selenium pretreatment tended to decrease hepatic and plasma tocopherol levels. To explain the effects observed in the present investigation, various mechanisms were discussed. If the compounds were acting as antioxidants, then the difference in intracellular localization had to be important. More likely a specific biochemical function involving drug metabolizing enzymes could be involved. Finally vitamin E...Continue Reading

References

Apr 15, 1977·Biochemical Pharmacology·R C CottrellS D Gangolli
Feb 1, 1976·CRC Critical Reviews in Toxicology·A T Diplock
Jul 1, 1976·The Medical Clinics of North America·S Schwarz
Jan 1, 1976·Archives of Biochemistry and Biophysics·L R HornM Brin
Jun 1, 1977·Toxicology and Applied Pharmacology·R Kahl, K J Netter
Oct 1, 1977·Toxicology and Applied Pharmacology·J U SkaareH K Dahle
Jul 1, 1976·Lipids·S L TaylorA L Tappel
Oct 1, 1976·Experimental and Molecular Pathology·A K Ghoshal
Jan 1, 1976·The Journal of International Medical Research·J KelleherM S Losowsky
Jan 1, 1971·Zeitschrift Für Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology·D Hadjiolov
Dec 15, 1974·Biochemical Pharmacology·D V ParkeR Walker
Jul 1, 1974·Biochemical Pharmacology·D V ParkeR Walker
Apr 17, 1972·Annals of the New York Academy of Sciences·O A Levander
May 10, 1972·Nature: New Biology·A SomogyiB Solymoss
Dec 1, 1974·The Proceedings of the Nutrition Society·A T Diplock
Dec 18, 1972·Annals of the New York Academy of Sciences·M P Carpenter
Jan 1, 1967·Advances in Cancer Research·P N Magee, J M Barnes
Jun 1, 1971·CRC Critical Reviews in Clinical Laboratory Sciences·R J Shamberger, C E Willis
Sep 1, 1970·The Journal of Nutrition·O A Levander, V C Morris
Apr 1, 1965·Experimental and Molecular Pathology·N R DILUZIO, F COSTALES
May 1, 1965·Archives of Biochemistry and Biophysics·I D DESAI, M L SCOTT

❮ Previous
Next ❯

Citations

Jan 1, 1982·Annals of the New York Academy of Sciences·P B McCayE K Lai
Apr 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S J MuñozW C Maddrey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.